Supporting the Government to Expand the Coverage of COVID-19 Vaccination in Indonesia, Prodia Ready to Serve the Independent Vaccination Program

JAKARTA, 9 July 2021 – PT Prodia Widyahusada Tbk (Stock code: PRDA) is ready to support the Independent Vaccination program starting in June 2021. Gotong Royong or Independent Vaccination Program is a vaccination for employees and their families funded by the company. The services of independent vaccination program can only be performed in health care facilities that meet the requirements. As one of the selected health facilities for independent vaccination program, Prodia has clinical services that can perform the vaccination for all employees and their family members.

President Director of Prodia Dewi Muliaty said, "As a form of Prodia's commitment to support the government on expanding the coverage of COVID-19 vaccination in Indonesia, we are ready to partner with business entities, both private and state-owned, for independent vaccination services at Prodia health care facilities. Through the independent vaccination program, we expect to be able to contribute in accelerating the formation of herd immunity in Indonesia," said Dewi in Jakarta, (09/07)

The procedure of vaccination is refer to service standards and standard operating procedures set by each head of health care facilities in accordance with the technical instructions for the implementation of vaccination from the Ministry of Health. Each health care facilities that carry out Gotong Royong vaccination services must record and report electronically through the COVID-19 Vaccination One Data Information System. The types of vaccines given in the Independent Vaccination program include Sinopharm which is distributed by PT Biofarma.

The Independent Vaccination Program is carried out in stages, the first phase starting on May 18, 2021, until 2022. The implementation of the COVID-19 vaccine services at Prodia is carried out after being appointed as a vaccinator and selected by the company.

56 Prodia’s branches are being prepared to support the independent vaccination program including Medan S. Parman, Banda Aceh, Batam, Pekanbaru, Jambi, Kramat, Kemang, Bintaro, Kelapa Gading, Bogor (Pajajaran), Prodia Senior Health Center Jakarta , Prodia Women's Health Center Jakarta, Tangerang, Depok, Bekasi, Lampung, BSD, Bandung, Karawang, Solo, Yogyakarta, Surabaya Diponegoro, Mataram, Kupang, Denpasar, Banjarmasin, Pontianak, Samarinda, Makassar, Panakukkang, Manado, Gorontalo, Kendari, Palu, Ternate Sorong, Palembang, Sunter, Malang, Balikpapan, Palangkaraya, Kotamobagu and Jayapura.

In its implementation, Prodia continues to have coordination with the local Health Department Office (Dinkes) regarding this Independent Vaccination service. Up to now, 17 Prodia’s branches are ready to serve the independent vaccinations, 19 branches have been visited by the Health Office and are waiting to be given PCare account, and 20 other branches are still waiting visitation schedule from the local Health Department Office. Since the end of June 2021 until now, Prodia has served several companies for independent vaccination program and committed to support the government for independent vaccination program.

Prodia’s Performance

Regarding the Implementation of Emergency Community Activity Restrictions (PPKM), which took place from 3-20 July 2021, the Company recorded an increase in the number of Home Service request about 2-3 times. In addition, the number of requests for esoteric tests also increased by 2 times as of July 7, 2021. Orders for medical checkup through Prodia Mobile also experienced a significant increase to 3 times.

In the first quarter of 2021, the number of testing reached 4.2 million and the number of visits reached 833,260. The number of requests for esoteric tests increased by 279.7% to 516,711 tests. The company managed to book a current ratio of 686.8% and a fast ratio of 661.0%. This financial ratio also reflects Prodia's balance sheet which is also getting stronger.

About PT Prodia Widyahusada Tbk

Prodia Clinical Laboratory was initially established in Solo on 7 May 1973 by a group of idealist pharmacists. From the very first, Andi Wijaya, along with the other founders have been committed to present the best test results with wholehearted services.

As the market leader, since 2012 Prodia has been the only laboratory and clinic in Indonesia accredited by the College of American Pathologists (CAP). It implies that Prodia' s test results are equal in quality to those obtained from other international laboratories.

On 7 December 2016, the Indonesia Stock Exchange officially listed the initial public offering of Prodia as the 15th issuer in 2016, with the ticker symbol 'PRDA'. In that corporate action, Prodia offered 187.5 million shares. Accordingly, the fund raised from the Company' s initial public offering (IPO) was Rp1.22 trillion.

Currently, Prodia has had the service network that incorporates 269 outlets, across 127 cities and 34 provinces in Indonesia, Prodia Health Care (PHC) - a personalized medicine-based wellness clinic - and specialty clinics, including Prodia Children' s Health Centre (PCHC), Prodia Women' s Health Centre (PWHC), and Prodia Senior Health Centre (PSHC).

Prodia has launched Kontak Prodia 1500-830 and the online-based virtual personal assistant Tanya Prodia (TANIA). TANIA can be accessed by anyone, especially Prodia customers directly anytime and anywhere online including via LINE: @prodia.id, Telegram: @prodia.id, Facebook Messenger: @prodia.id and Prodia Website: www.prodia.co.id.

For more information, please visit www.prodia.co.id or contact: